Notably, soluble Sema4D levels have been found to be elevated in the serum and synovial fluid of patients with RA, and the administration of anti-Sema4D ameliorated inflammation in type II collagen-induced arthritis in mice [16]. The gene discussed is SEMA4D; the disease is rheumatoid arthritis.